H.R. 4993 · 119th Congress · Health

Joe Fiandra Access to Home Infusion Act of 2025

Expands Medicare coverage for home infusion therapy services and supplies. AI-read

In committee309 words Introduced Aug 19, 2025 · Latest action Dec 10, 2025

How far it has goneStage 2 of 6
  1. IntroducedAug 19, 2025 Done
  2. CommitteeReferred to 2 committees Current stage
  3. House floorNot yet Not reached yet
  4. Senate floorNot yet Not reached yet
  5. Chambers agreeNot yet Not reached yet
  6. PresidentNot yet Not reached yet

Became law inside another bill: its text was enacted in H.R. 7148 (Consolidated Appropriations Act, 2026), signed Feb 3, 2026. The bar shows how far this bill got under its own number.

What it does

This bill provides for Medicare coverage of certain home infusion drugs that are administered by health care professionals at a beneficiary’s home.

Specifically, the bill provides for coverage of external infusion pumps and associated home infusion drugs for which (1) the prescription requires that the drug be administered by or under the supervision of a health care professional, (2) a qualified home infusion therapy supplier administers or supervises the administration of the drug at the beneficiary's home, and (3) the prescription requires that the drug be infused at least 12 times per year in a manner that requires the use of an external infusion pump.

Congressional Research Service · summary of “Introduced in House” version · Aug 19, 2025

Who lobbies on it

2 organizations, more than 77% of House bills · 7 filings · Q3 2025–Q3 2026

See which of this bill’s sponsors and cosponsors got money from the lobbying organizations’ PACs → Pro

One square per quarter since introduction, oldest left. Filled = named it that quarter.

  1. Alnylam Pharmaceuticals, Inc. 5 of 5 quarters
    “Issues related to the implementation of the Inflation Reduction Act; HR.4993, Joe Fiandra Access to Home Infusion Act; issues related to MFN drig pricing”

    $1.4M lobbying spend in 2026 to date, all issuesQ3 2026 filing

  2. Ucb, Inc. 2 of 5 quarters
    “HR 4993 - Joe Fiandra Access to Home Infusion Act of 2025 HR 4317 - PBM Reform Act of 2025”

    $1.6M lobbying spend in 2025, all issuesQ4 2025 filing

Organizations that named H.R. 4993 in a quarterly lobbying report. Covers organizations with a PAC on file; reports from organizations without one aren’t loaded yet. Spend is the organization’s total across all issues: reports don’t split spending by bill. “Gave to” means the organization’s PAC gave to the member’s campaign in the 2025–26 cycle, net of refunds; it doesn’t mean the money was about this bill. Organizations may lobby for, against, or to change a bill; filings don’t say which. Source: Senate lobbying disclosures (LD-2) from lda.gov; PAC gifts from FEC filings; quotes are word for word from the “specific lobbying issues” field; where a filing lists many bills, the quote starts where it names this one.

Actions

4 actions · newest first
  1. Dec 10, 2025Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 41 - 0.
  2. Dec 10, 2025Committee Consideration and Mark-up Session Held
  3. Aug 19, 2025Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  4. Aug 19, 2025Introduced in House